TY  - JOUR
AU  - Cariolou, Margarita
AU  - Christakoudi, Sofia
AU  - Gunter, Marc J
AU  - Key, Tim
AU  - Pérez-Cornago, Aurora
AU  - Travis, Ruth
AU  - Zamora-Ros, Raul
AU  - Petersen, Kristina Elin T
AU  - Tjønneland, Anne
AU  - Weiderpass, Elisabete
AU  - Kaaks, Rudolf
AU  - Seibold, Petra
AU  - Inan-Eroglu, Elif
AU  - Schulze, Matthias B
AU  - Masala, Giovanna
AU  - Agnoli, Claudia
AU  - Tumino, Rosario
AU  - Di Girolamo, Chiara
AU  - Aizpurua, Amaia
AU  - Rodriguez-Barranco, Miguel
AU  - Santiuste, Carmen
AU  - Guevara, Marcela
AU  - Aune, Dagfinn
AU  - Chan, Doris Sm
AU  - Muller, David C
AU  - Tsilidis, Konstantinos K
TI  - Adiposity assessed close to diagnosis and prostate cancer prognosis in the EPIC study.
JO  - JNCI cancer spectrum
VL  - 8
IS  - 5
SN  - 2515-5091
CY  - Oxford
PB  - Oxford University Press
M1  - DKFZ-2024-01724
SP  - pkae070
PY  - 2024
N1  - 2024 Sep 2;8(5):pkae070
AB  - Adiposity has been characterised as a modifiable risk factor of prostate cancer. Its association with outcomes after prostate cancer diagnosis, however, needs to be better understood and obtain more evidence to assist the development of lifestyle guidance for prostate cancer patients.We investigated the associations between adiposity indices close to prostate cancer diagnosis (up to two years pre- or up to five years post-diagnosis) and mortality in 1,968 men of the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Men were followed for a median of 9.5 years. Cox proportional-hazards models were adjusted for age and year of diagnosis, stage, grade, smoking and stratified by country.Each 5-unit increment in pre- or post-diagnosis body mass index (BMI) combined was associated with a 30
KW  - adiposity (Other)
KW  - lifestyle (Other)
KW  - mortality (Other)
KW  - prostate cancer (Other)
KW  - survival (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:39180334
DO  - DOI:10.1093/jncics/pkae070
UR  - https://inrepo02.dkfz.de/record/292457
ER  -